S1 Versus Capecitabine in the First Line Treatment of Metastatic Colorectal Cancer Patients, the SALTO Randomised Phase III Study of the Dutch Colorectal Cancer Group. A Safety Evaluation of Oral Fluoropyrimidines
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2018
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Bevacizumab; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SALTO
- 31 Aug 2018 Biomarkers information updated
- 13 Mar 2018 Status changed from active, no longer recruiting to completed.
- 15 Aug 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016.